Literature DB >> 11297589

Laparoscopic adrenalectomy for adrenocorticotropin-dependent Cushing's syndrome.

A Vella1, G B Thompson, C S Grant, J A van Heerden, D R Farley, W F Young.   

Abstract

Bilateral adrenalectomy is indicated for the treatment of ACTH-dependent Cushing's syndrome when the tumorous source of ACTH hypersecretion cannot be identified or removed. Potential advantages of laparoscopic over open adrenalectomy include shorter hospitalization, decreased requirement for postoperative analgesia, and decreased postoperative morbidity due to incisional complications. Bilateral laparoscopic adrenalectomy performed for the treatment of ACTH-dependent Cushing's syndrome was attempted in 19 patients at our institution between 1995 and 1998. Conversion to an open procedure was required in three patients. All patients who underwent bilateral laparoscopic adrenalectomy were subsequently followed to assess the outcome of this intervention. Twelve patients with pituitary-dependent Cushing's syndrome and four with ectopic ACTH syndrome underwent successful bilateral laparoscopic adrenalectomy. All patients experienced resolution of the signs and symptoms (e.g. proximal myopathy, hirsutism, and emotional lability) of Cushing's syndrome as well as weight loss, improved glucose tolerance, and improved control of blood pressure. No residual cortisol secretion was detected in the patients. Bilateral laparoscopic adrenalectomy is a safe and effective treatment for Cushing's syndrome when the ACTH-secreting neoplasm cannot be removed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11297589     DOI: 10.1210/jcem.86.4.7399

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

1.  Factors affecting the surgical approach and timing of bilateral adrenalectomy.

Authors:  Billy Y Lan; Halit E Taskin; Erol Aksoy; Onur Birsen; Cem Dural; Jamie Mitchell; Allan Siperstein; Eren Berber
Journal:  Surg Endosc       Date:  2014-11-01       Impact factor: 4.584

Review 2.  Bilateral adrenalectomy for Cushing's disease.

Authors:  Laurence Katznelson
Journal:  Pituitary       Date:  2015-04       Impact factor: 4.107

Review 3.  The Treatment of Cushing's Disease.

Authors:  Rosario Pivonello; Monica De Leo; Alessia Cozzolino; Annamaria Colao
Journal:  Endocr Rev       Date:  2015-06-11       Impact factor: 19.871

4.  Laparoscopic bilateral anterior transperitoneal adrenalectomy: 24 years experience.

Authors:  Andrea Balla; Monica Ortenzi; Livia Palmieri; Diletta Corallino; Francesca Meoli; Pietro Ursi; Giulia Puliani; Emilia Sbardella; Andrea M Isidori; Mario Guerrieri; Silvia Quaresima; Alessandro M Paganini
Journal:  Surg Endosc       Date:  2019-01-23       Impact factor: 4.584

Review 5.  The Nelson's syndrome... revisited.

Authors:  Guillaume Assié; Hélène Bahurel; Jérôme Bertherat; Michèle Kujas; Paul Legmann; Xavier Bertagna
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

Review 6.  Management of Cushing disease.

Authors:  Nicholas A Tritos; Beverly M K Biller; Brooke Swearingen
Journal:  Nat Rev Endocrinol       Date:  2011-02-08       Impact factor: 43.330

7.  Simultaneous bilateral laparoscopic adrenalectomy is safe for synchronous large adrenal tumors.

Authors:  Giovanni Ramacciato; Paolo Mercantini; Marco La Torre; Nicola De Ruvo; Giorgio Ercolani; Antonio Stigliano; Vincenzo Toscano
Journal:  JSLS       Date:  2006 Jul-Sep       Impact factor: 2.172

Review 8.  Medical management of Cushing's disease.

Authors:  Nicholas A Tritos; Beverly M K Biller
Journal:  J Neurooncol       Date:  2013-10-22       Impact factor: 4.130

9.  Laparoscopic bilateral adrenalectomy: results for 30 consecutive cases.

Authors:  M C Takata; E Kebebew; O H Clark; Q-Y Duh
Journal:  Surg Endosc       Date:  2008-01       Impact factor: 4.584

Review 10.  Synchronous bilateral endoscopic adrenalectomy: experiences after 18 operations.

Authors:  F Jäger; E Jäger; A Heintz; T Junginger
Journal:  Surg Endosc       Date:  2003-12-29       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.